Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions
Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, et al
The STEP 4 trial (Rubino et al., JAMA, 2021) similarly showed roughly 6.9% regain over 48 weeks in those who stopped, versus continued loss in those who kept taking semaglutide
42 BhakkiyalakshmiE.DineshkumarK.KarthikS.SireeshD.HopperW.PaulmuruganR.et al (2016)
It provides a comprehensive and up-to-date overview of the broad therapeutic landscape of GLP-1 RAs by consolidating the findings from multiple large-scale, randomized controlled trials (n = 15 publications)